Start free

CapsoVision, Inc (CV) Stock: Financials, SEC Filings & Ownership

CapsoVision, Inc (CV) reported trailing twelve-month revenue of $13.9M (up 11.0% year on year) and net income of -$29.8M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Market cap: $349.8M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CVCapsoVision, IncFollow CV — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
349.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 18 days

Price

The price chart — with earnings days, unusual moves, 8-Ks and insider trades marked — opens with a free account.

Analyst

Our read on this company

The verdict, the score behind it and the written thesis are in Analyst.

Try it free for 7 days

Timing

Analyst

Today's price conditions

The verdict, the score behind it and the written thesis are in Analyst.

Try it free for 7 days

Analyst note

Analyst

Our written read on this company

The verdict, the score behind it and the written thesis are in Analyst.

Try it free for 7 days

Dividends & buybacks

yield — · payout —

No dividends or buybacks in the filed statements.

Performance

price return · vs. S&P 500 and the sector
WindowCVvs. S&P 500vs. sector
1 month+13.3%——
3 months+5.8%——
6 months+15.2%——
Year to date-31.7%——
1 year+41.5%——

CapsoVision, Inc — questions

What does CapsoVision, Inc do?
CapsoVision, Inc is a medical devices company in the healthcare sector. In its SEC filings it reports 2 business lines: Product (93%), Service (7%). Trailing twelve-month revenue: $13.9 million as of 2026-06-30.
What is CapsoVision, Inc's revenue?
$13.9M over the twelve months to 2026-06-30, up 11.0% year on year, from its 10-Q and 10-K filings.
What is CapsoVision, Inc's market cap?
$349.8M.
Who owns CapsoVision, Inc stock?
50 institutions reported CapsoVision, Inc shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (3.8%), VANGUARD CAPITAL MANAGEMENT LLC (2.1%), GEODE CAPITAL MANAGEMENT, LLC (1.2%).
When does CapsoVision, Inc report earnings?
CapsoVision, Inc's next earnings report is expected on 2026-11-12.
What sector is CapsoVision, Inc in?
CapsoVision, Inc is in the Healthcare sector, Medical Devices industry.
Who are CapsoVision, Inc's competitors?
The nearest listed peers by market cap in Medical Devices: AVITA Medical, Inc. (RCEL), 908 Devices Inc. (MASS), Cerus Corporation (CERS), NeuroPace, Inc. (NPCE), Orthofix Medical Inc. (OFIX).

Every figure on this page comes from CapsoVision, Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

Peers and related: AVITA Medical, Inc. (RCEL) · 908 Devices Inc. (MASS) · Cerus Corporation (CERS) · NeuroPace, Inc. (NPCE) · Orthofix Medical Inc. (OFIX) · All Medical Devices companies

How these figures are read: methodology · EquiReason.